Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Currie P. J., Kelly M. J., Middlebrook K., Federman J., Sainsbury E., Ashley J., Pitt A. Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure. Br Heart J. 1984 May;51(5):530–538. doi: 10.1136/hrt.51.5.530. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dawson J. R., Bayliss J., Norell M. S., Canepa-Anson R., Kuan P., Reuben S., Poole-Wilson P. A., Sutton G. C. Clinical studies with beta 2 adrenoceptor agonists in heart failure. Eur Heart J. 1982 Dec;3 (Suppl 500):135–141. [PubMed] [Google Scholar]
- Glover D. R., Wathen C. G., Murray R. G., Petch M. C., Muir A. L., Littler W. A. Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo. Br Heart J. 1985 Feb;53(2):208–215. doi: 10.1136/hrt.53.2.208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lambertz H., Meyer J., Erbel R. Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure. Circulation. 1984 Feb;69(2):298–305. doi: 10.1161/01.cir.69.2.298. [DOI] [PubMed] [Google Scholar]